NCT07012759 Pleural Effusion Biomarkers in Lung Adenocarcinoma Patients
| NCT ID | NCT07012759 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Fu Jen Catholic University |
| Condition | Biomarkers |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-06-10 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2025-06-10 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This project aims to assess the expression levels of novel molecular markers identified through screening in clinical samples of malignant pleural effusion, to evaluate the feasibility and clinical utility of these markers as potential diagnostic genes for lung adenocarcinoma.
Eligibility Criteria
Inclusion Criteria: * Patients requiring thoracentesis for pleural effusion drainage as determined by a physician based on clinical need. * Signed informed consent. Exclusion Criteria: * Patients under the age of 18. * Patients with malignancies other than lung adenocarcinoma.
Contact & Investigator
Ke-Yun Chao, PhD
PRINCIPAL INVESTIGATOR
Fu Jen Catholic University
Frequently Asked Questions
Who can join the NCT07012759 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Biomarkers. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07012759 currently recruiting?
Yes, NCT07012759 is actively recruiting participants. Contact the research team at ck_qq@hotmail.com for enrollment information.
Where is the NCT07012759 trial being conducted?
This trial is being conducted at New Taipei City, Taiwan.
Who is sponsoring the NCT07012759 clinical trial?
NCT07012759 is sponsored by Fu Jen Catholic University. The principal investigator is Ke-Yun Chao, PhD at Fu Jen Catholic University. The trial plans to enroll 100 participants.